HomeIndustriesTechnologyBiotech Outlook: Funding, M&A Development & Biotech's 'A.I. Equivalent'
00:00
00:00
07:48
Biotech Outlook: Funding, M&A Development & Biotech's 'A.I. Equivalent'

Biotech Outlook: Funding, M&A Development & Biotech's 'A.I. Equivalent'

According to Mara Goldstein, the biotech industry is in "voracious" need for funding. She says the sector has not seen a tremendous amount of funding in years, which could change if M&A activity increases under a new administration. Mara discusses the "blockbuster" drugs will shake up the industry and biotech's "A.I. equivalents"

Morning Trade Live

31 Jan 2025

SHARE

ON AIR
12:00 am
Market Overtime
replay
education
5:00 am
Your First Trade
REPLAY
education
5:30 am
Your First Trade
REPLAY
6:00 am
The Wrap
REPLAY
education
7:00 am
Your First Trade
REPLAY
education
7:30 am
Your First Trade
REPLAY
8:00 am
Market Overtime
REPLAY
9:00 am
Market Overtime
REPLAY
education
9:30 am
Inside the Mind of a Trader
REPLAY
education
10:00 am
Inside the Mind of a Trader
REPLAY
education
10:30 am
Inside the Mind of a Trader
REPLAY
11:00 am
The Wrap
REPLAY
12:00 pm
Morning Movers
1:00 pm
Morning Trade Live
3:00 pm
Trading 360
4:00 pm
Fast Market
5:00 pm
Next Gen Investing
6:00 pm
The Watch List
7:00 pm
Market On Close
8:30 pm
Market Overtime
REPLAY
9:00 pm
Fast Market
REPLAY
10:00 pm
Next Gen Investing
REPLAY
11:00 pm
The Wrap
REPLAY
ON AIR
12:00 am
Market Overtime
REPLAY
12:30 am
Market Overtime
REPLAY
1:00 am
The Wrap
REPLAY
2:00 am
Market Overtime
REPLAY
2:30 am
Market Overtime
REPLAY
3:00 am
Fast Market
REPLAY
4:00 am
Next Gen Investing
REPLAY

Schwab Network's Newsletters

Daily insights for every investor